Abstract

We used two, 3-min field stimulation cycles 30 min apart (S1, S2) in 3H-norepinephrine-loaded, superfused rat nucleus tractus solitarii-dorsal motor vagal nucleus (NTS-DVN) slices. The stimulation-induced release was expressed as the area above the baseline. Drugs were introduced 12 min before S2 and drug actions were characterized in terms of alterations of S2/S1 ratios. The S2/S1 ratio was 1.047 (0.946–1.159, n=4, geometric mean and 95% confidence interval) in controls and 0.336 (0.230–0.490, n=3), 0.726 (0.590–0.892, n=4), 0.613 (0.594–0.683, n=4) and 0.665 (0.500–0.886, n=4) in the presence of 10 −6 M clonidine, d-Ala 2,MePhe 4,Gly 5-ol-enkephalin (DAMGO), endomorphin-1 (Tyr–Pro–Trp–Phe–NH 2, EM-1) and -2 (Tyr–Pro–Phe–Phe–NH 2, EM-2) [the latter two in the presence of 10 −4 M diprotin A, an inhibitor of dipeptidyl-aminopeptidase IV (DAP-IV) enzyme]. The effect of DAMGO at 10 −5 M was significantly higher than at 10 −6 M, whereas the effect of endomorphins did not differ at the two concentration levels. Diprotin A potentiated only very modestly the action of endomorphins. These data (a) confirm the presence of functional μ-opioid receptors in the vagal complex, (b) render it likely that the enzymic degradation of endomorphins is not a highly effective process in brain slices and (c) may suggest that the apparent ceiling in the effect of endomorphins might be related to their partial agonist property.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.